Clinica EUGIN, Barcelona, Spain.
Department of Genetics, Microbiology and Statistics, Universitat de Barcelona, Barcelona, Spain.
Hum Reprod. 2020 Oct 1;35(10):2262-2271. doi: 10.1093/humrep/deaa178.
Is oocyte vitrification/warming as efficient and effective as using fresh oocytes in donation cycles?
IVF with vitrified donor oocytes is less efficient than using fresh oocytes, but its efficacy remains comparable to that of fresh cycles.
Oocyte vitrification is used to preserve the reproductive potential of oocytes. A small number of randomized controlled trials carried out by experienced groups have shown that this technique provides fertilization, pregnancy, implantation and ongoing pregnancy rates comparable to those of fresh oocytes. However, large registry-based analyses have consistently reported lower live birth rates (LBRs) in cycles using vitrified oocytes. It is not clear whether this decrease may be due to the effect of vitrification per se on the oocytes or to the lower efficiency of the technique, as some of the oocytes do not survive after warming.
STUDY DESIGN, SIZE, DURATION: Retrospective cohort analysis of 1844 cycles of oocyte donation (37 520 oocytes), each donor in the study provided enough oocytes for at least one reception cycle with fresh oocytes (2561 cycles) and one reception cycle with vitrified oocytes (2471 cycles) from the same ovarian stimulation (sibling oocytes). Overall, 35 654 oocytes were considered in the analysis. All embryo transfers (n = 5032) were carried out between 2011 and 2017.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Differences in reproductive outcomes after the first embryo transfer were evaluated using Pearson's Chi-squared test and regression analysis adjusted for recipient's age, BMI, sperm origin and state, day of embryo transfer, morphological score and number of transferred embryos. We performed two additional sub-analyses, to test whether the efficiency and/or effectiveness of vitrification/warming impacts reproductive results. One analysis included paired cycles where the same number of fresh and vitrified oocytes were available for ICSI (SAME sub-analysis), while the second analysis included those cycles with a 100% survival rate post-warming (SAME100 sub-analysis).
Baseline and cycle characteristics of participants were comparable between groups. Overall, fertilization rates and embryo morphological scores were significantly lower (P < 0.001) when using vitrified oocytes; moreover, vitrified oocytes also resulted in lower reproductive outcomes than sibling fresh oocytes using both unadjusted and adjusted analyses: ongoing pregnancy (32.1% versus 37.5%; P < 0.001; OR 0.88, 95% CI 0.77, 1.00) and live birth (32.1% versus 31.9%; P = 0.92; OR 1.16, 95% CI 0.90, 1.49). However, when the efficiency of warming was taken into account, reproductive outcomes in recipients became comparable: ongoing pregnancy (33.5% versus 34.1%; P = 0.82; OR 1.11, 95% CI 0.87, 1.43) and LBR (32.1% versus 32%; P = 0.97; OR 1.15, 95% CI 0.89, 1.48). Moreover, after selecting only cycles that, in addition to having the same number of oocytes available for ICSI, also had 100% post-warming survival rate in the vitrified group, reproductive outcomes were also comparable between fresh and vitrified oocytes: ongoing pregnancy (34.8% versus 32.4%; P = 0.42; OR 1.32, 95% CI 0.98, 1.77) and live birth (32.9% versus 31.0%; P = 0.52; OR 1.27, 95% CI 0.95, 1.71), indicating that reproductive outcomes of these cycles are affected by the efficiency of the vitrification/warming technique performed rather than the oocyte damage due to the fast cooling process to which oocytes are subjected.
LIMITATIONS, REASONS FOR CAUTION: An open vitrification system was used for all cases, and oocyte vitrification/warming was performed by experienced embryologists with consistently high survival rates; caution must be exerted when extrapolating our results to data obtained using other open vitrification systems, closed vitrification systems or to IVF units with survival rates <90%.
This is the largest cohort study comparing reproductive outcomes of vitrified and fresh sibling donor oocytes to date. We found that, when the number of oocytes available after warming is equal to the number of fresh oocytes, reproductive results including live birth are comparable. Consequently, the efficiency of vitrification must be taken into account to achieve the same reproductive outcomes as with fresh oocytes. We recommend implementing strict indicators of vitrification/warming efficiency in clinics and refining vitrification/warming protocols to maximize survival.
STUDY FUNDING/COMPETING INTEREST(S): This work was supported by intramural funding of Clínica EUGIN and by the Secretary for Universities and Research of the Ministry of Economy and Knowledge of the Government of Catalonia (GENCAT 2015 DI 048). The authors declare no conflicts of interest.
N/A.
卵母细胞玻璃化/解冻与新鲜卵母细胞在捐赠周期中的使用效率和效果是否相同?
使用玻璃化供体卵母细胞进行 IVF 的效率低于使用新鲜卵母细胞,但它的效果仍然与新鲜周期相当。
卵母细胞玻璃化用于保存卵母细胞的生殖潜力。少数由经验丰富的小组进行的随机对照试验表明,该技术提供的受精率、妊娠率、着床率和持续妊娠率与新鲜卵母细胞相当。然而,大型基于注册的分析一直报告说,使用玻璃化卵母细胞的周期中的活产率(LBR)较低。目前尚不清楚这种下降是否可能是由于卵母细胞本身的玻璃化作用,还是由于该技术的效率较低,因为一些卵母细胞在解冻后无法存活。
研究设计、大小、持续时间:对 1844 个卵母细胞捐赠周期(37520 个卵母细胞)的回顾性队列分析,每个供体在研究中提供的卵母细胞数量至少足以进行一次新鲜卵母细胞(2561 个周期)和一次玻璃化卵母细胞(2471 个周期)的接受周期,均来自同一卵巢刺激(同胞卵母细胞)。总共考虑了 35654 个卵母细胞进行分析。所有胚胎移植(n=5032)均在 2011 年至 2017 年之间进行。
参与者/材料、设置、方法:使用 Pearson's Chi-squared 检验和回归分析评估第一次胚胎移植后的生殖结果差异,回归分析调整了受者的年龄、BMI、精子来源和状态、胚胎移植日、形态评分和移植胚胎数量。我们进行了两项额外的亚分析,以测试玻璃化/解冻的效率和/或效果是否会影响生殖结果。一项分析包括可用于 ICSI 的新鲜和玻璃化卵母细胞数量相同的配对周期(SAME 亚分析),而第二项分析包括解冻后存活率为 100%的周期(SAME100 亚分析)。
参与者的基线和周期特征在组间具有可比性。总体而言,使用玻璃化卵母细胞时受精率和胚胎形态评分显著降低(P<0.001);此外,使用玻璃化卵母细胞还导致活产率(32.1%对 31.9%;P=0.92;OR 1.16,95%CI 0.90,1.49)和持续妊娠率(32.1%对 31.9%;P=0.92;OR 1.16,95%CI 0.90,1.49)低于同胞新鲜卵母细胞。然而,当考虑到解冻效率时,受者的生殖结果变得相当:持续妊娠率(33.5%对 34.1%;P=0.82;OR 1.11,95%CI 0.87,1.43)和活产率(32.1%对 32%;P=0.97;OR 1.15,95%CI 0.89,1.48)。此外,在选择除了具有相同数量的卵母细胞可用于 ICSI 外,还具有解冻后存活率为 100%的玻璃化组的周期后,新鲜卵母细胞和玻璃化卵母细胞的生殖结果也相当:持续妊娠率(34.8%对 32.4%;P=0.42;OR 1.32,95%CI 0.98,1.77)和活产率(32.9%对 31.0%;P=0.52;OR 1.27,95%CI 0.95,1.71),表明这些周期的生殖结果受到玻璃化/解冻技术的效率影响,而不是卵母细胞由于快速冷却过程而受到的卵母细胞损伤的影响。
局限性、谨慎的原因:所有病例均使用开放式玻璃化系统,卵母细胞玻璃化/解冻由经验丰富的胚胎学家进行,存活率一直很高;当将我们的结果外推到使用其他开放式玻璃化系统、封闭式玻璃化系统或存活率<90%的 IVF 单位获得的数据时,必须谨慎。
这是迄今为止比较冷冻和新鲜同胞供体卵母细胞生殖结果的最大队列研究。我们发现,当解冻后可用的卵母细胞数量与新鲜卵母细胞数量相同时,包括活产率在内的生殖结果是相当的。因此,必须考虑到玻璃化的效率以达到与新鲜卵母细胞相同的生殖结果。我们建议在诊所实施严格的玻璃化/解冻效率指标,并改进玻璃化/解冻方案,以最大限度地提高存活率。
研究资金/利益冲突:这项工作得到了 Clínica EUGIN 的内部资金和加泰罗尼亚政府经济和知识部(GENCAT 2015 DI 048)的支持。作者没有利益冲突。
无。